09:52 AM EST - Amorfix Life Sciences Ltd. : announced today that it intends to complete, subject to regulatory approval, a non-brokered private placement of between approximately 2,222,222 units at a price of $0.225 per Unit, for gross proceeds of $500,000, and approximately 4,444,444 Units at a price of $0.225 per Unit, for gross proceeds of $1,000,000. Each Unit will consist of one common share of Amorfix and one common share purchase warrant of Amorfix. Each Warrant will entitle the holder to purchase one Share at a price of $0.50 for a period of 36 months following the closing date of the Offering, subject to earlier expiry in the event (a trigger event) that, following the expiry of the four month hold period, the volume-weighted average price of Amorfix's common shares on the Toronto Stock Exchange over a period of 20 consecutive trading days exceeds $1.00. Amorfix Life Sciences Ltd.
shares T.AMF are trading even at $0.21.
